Learn More
Selleck Chemical LLC Erdafitinib (JNJ-42756493) 5mg 1346242-81-6

Supplier: Selleck Chemical LLC S84015MG
Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Erdafitinib also binds to RET (c-RET), CSF-1R, PDGFR-?/PDGFR-?, FLT4, Kit (c-Kit) and VEGFR-2 and induces cellular apoptosis. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.